, /PRNewswire/ -- , a pioneer in the fusion of behavioral science and artificial intelligence to deliver better health outcomes, announced today it is launching a second intervention focusing on diabetes with , one of the largest and most comprehensive health networks in . The initiative builds on the strategic partnership announced in 2023, and it aligns with Cone Health's focus on managing chronic conditions, improving the patient experience and advancing health equity. It also represents the first enterprise agreement for Lirio.
The expanded strategic partnership means Cone Health will use Lirio's Precision Nudging solution to target behavior changes from its hypertensive and diabetic patient populations. The goal for Cone Health is to better manage chronic conditions, lower costs and improve patient satisfaction. Plans call for having five different Lirio interventions in place by the end of the year.
"This next step in our strategic partnership with Cone Health introduces adaptive intervention design that is only possible with cutting-edge behavioral science and AI," said , CEO of Lirio. "We're confident that our unique approach to behavior change will help Cone Health offer just-in-time personalized support for patients with hypertension, diabetes, and other chronic conditions, and we are thrilled to partner with an organization that shares our commitment to health equity." Cone Health serves the Piedmont Triad of , a racially diverse region of nearly 2 million people t.